Contact Us
Subscribe
E-Edition

39°

Site search

Open user controls
- Log In Using Your Account
  Log In
  
  Don't have an account? Sign Up Today

- My Account
- Dashboard
- Profile
- Saved items
- Logout

Home
News
Sports
Obits
Multimedia
- Photo Galleries
- Videos
e-Edition
Classifieds
Subscribe
Archives
Best of 2026

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

MediWound Ltd. - Ordinary Shares (NQ:MDWD)

17.62 -0.51 (-2.81%)

Streaming Delayed Price Updated: 10:47 AM EST, Feb 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about MediWound Ltd. - Ordinary Shares

< Previous 1 2 3 4 5 6 7 Next >

MediWound Announces Positive Results in U.S. Phase I/II Study of MW005 for the Treatment of Basal Cell Carcinoma

December 19, 2022

From MediWound Ltd.

Via GlobeNewswire

MediWound Expands Global Presence as NexoBrid® Gains Approval in India

December 13, 2022

Exclusive marketing and distribution agreement signed with Bharat Serum and Vaccines Limited (BSV), a leading biopharmaceutical company

From MediWound Ltd.

Via GlobeNewswire

MediWound Announces a 1-for-7 Reverse Share Split

December 05, 2022

From MediWound Ltd.

Via GlobeNewswire

Recap: MediWound Q2 Earnings ↗

August 09, 2022

MediWound (NASDAQ:MDWD) reported its Q2 earnings results on Tuesday, August 9, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

MediWound Posts Early Data From Non-Melanoma Skin Cancer Trial ↗

July 11, 2022

Via Benzinga

MediWound's EscharEx Shows Safe, Effective, Rapid Debridement Of Leg Ulcers ↗

July 07, 2022

Via Benzinga

Earnings Scheduled For November 15, 2022 ↗

November 15, 2022

Companies Reporting Before The Bell • Alkaline Water Co (NASDAQ:WTER) is likely to report quarterly loss at $0.05 per share on revenue of $18.31 million.

Via Benzinga

MediWound to Report Third Quarter 2022 Financial Results

November 03, 2022

Conference Call and Webcast Scheduled for Tuesday, November 15, 2022 at 8:30 am Eastern Time

From MediWound Ltd.

Via GlobeNewswire

MediWound: Q1 Earnings Insights ↗

May 17, 2022

MediWound (NASDAQ:MDWD) reported its Q1 earnings results on Tuesday, May 17, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

MediWound: Q4 Earnings Insights ↗

March 17, 2022

MediWound (NASDAQ:MDWD) reported its Q4 earnings results on Thursday, March 17, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings...

Via Benzinga

MediWound Earnings Preview ↗

March 16, 2022

MediWound (NASDAQ:MDWD) is set to give its latest quarterly earnings report on Thursday, 2022-03-17. Here's what investors need to know before the announcement. Analysts estimate...

Via Benzinga

MediWound Announces Formation of Strategic Advisory Board

October 25, 2022

Esteemed group of industry leaders to contribute expertise and experience to MediWound’s strategic and operational activities

From MediWound Ltd.

Via GlobeNewswire

MediWound's EscharEx® Featured in Oral and Poster Presentations at the Symposium on Advanced Wound Care (SAWC) Fall 2022

October 18, 2022

EscharEx’s promising results from the completed Phase 2 trials were highlighted

From MediWound Ltd.

Via GlobeNewswire

MediWound Announces Closing of the Concurrent Registered Direct and Private Placement Offerings

October 07, 2022

Gross Proceeds of $30.5 Million Raised

From MediWound Ltd.

Via GlobeNewswire

Why Avenue Therapeutics Shares Surged Around 106%; Here Are 87 Biggest Movers From Yesterday ↗

September 23, 2022

Gainers

Via Benzinga

Dow Turns Higher; Crude Oil Rises 0.7% ↗

September 22, 2022

U.S. stocks pared some losses, with the Dow Jones turning higher toward the end of trading on Thursday.

Via Benzinga

Why MediWound Is Trading Lower By Around 18%, Here Are 48 Stocks Moving In Thursday's Mid-Day Session ↗

September 22, 2022

Gainers

Via Benzinga

Nasdaq Drops Over 100 Points; Spero Therapeutics Shares Spike Higher ↗

September 22, 2022

U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping more than 100 points on Thursday.

Via Benzinga

Recap Of Wednesday's Biotech Catalysts - End Of the Day Summary ↗

August 03, 2022

Via Benzinga

FDA Accepts MediWound's Refiling For Severe Thermal Burns Therapy For Review ↗

August 03, 2022

The U.S. Food and Drug Administration (FDA) has accepted for review MediWound’s (NASDAQ: MDWD) recently re-submitted Biologics License Application (BLA) for its lead asset NexoBrid for eschar removal...

Via Benzinga

The Daily Biotech Pulse: Pfizer-BioNTech's COVID-19 Booster For Kids 5-11 Coming Soon, Ultragenyx In-Licenses Gene Therapy For Genetic Disorder, Ampio's AP-013 Trial Under Independent Investigation ↗

May 17, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Earnings Scheduled For May 17, 2022 ↗

May 17, 2022

Companies Reporting Before The Bell • On Holding (NYSE:ONON) is likely to report earnings for its first quarter.

Via Benzinga

Preview: MediWound's Earnings ↗

May 16, 2022

MediWound (NASDAQ:MDWD) is set to give its latest quarterly earnings report on Tuesday, 2022-05-17. Here's what investors need to know before the announcement. Analysts estimate that MediWound will...

Via Benzinga

The Week Ahead In Biotech: Gene & Cell Therapy Conference, Tapering Earnings News, OKYO Pharma IPO And More ↗

May 16, 2022

Biopharma stocks remained largely unchanged in the week ending May 13, with the defensive nature of the sector coming to its aid. Stocks reacted to the broader market move and earnings news from...

Via Benzinga

The Daily Biotech Pulse: Bristol Myers, BridgeBio Ink Oncology Pact, FDA Nod For Lava Therapeutics Blood Cancer Study And More ↗

May 12, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

MediWound Posts Promising EscharEx Data For Chronic Wounds ↗

May 12, 2022

MediWound Ltd (NASDAQ: MDWD) has announced results from its U.S. Phase 2 clinical study of EscharEx for the debridement of venous leg ulcers (VLUs).

Via Benzinga

The Daily Biotech Pulse: AbbVie's Rinvoq Gets Label Expansion, AstraZeneca COVID Antibody Cocktail Authorized By UK Regulator, Stealth Touts Positive Data ↗

March 17, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

36 Stocks Moving In Thursday's Mid-Day Session ↗

March 03, 2022

Gainers Indonesia Energy Corporation Limited (NASDAQ: INDO) shares jumped 46% to $21.13 after jumping around 35% on Wednesday. Eos Energy Enterprises, Inc. (NASDAQ: EOSE...

Via Benzinga

Earnings Scheduled For March 17, 2022 ↗

March 17, 2022

Companies Reporting Before The Bell • TransGlobe Energy (NASDAQ:TGA) is estimated to report earnings for its fourth quarter. • Ikena Oncology (NASDAQ:IKNA) is...

Via Benzinga

63 Biggest Movers From Yesterday ↗

March 04, 2022

Gainers Indonesia Energy Corporation Limited (NASDAQ: INDO) shares climbed 39.3% to close at $20.20 on Thursday after jumping around 35% on Wednesday. DBV Technologies S.A. (...

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

Home
News
Sports
Entertainment
Local Events
Obituaries
Multimedia
e-Edition
Online Features

Services

Subscription Services
Submission Forms
Classifieds
Place an Ad
Promote Your Event
Email Alerts
Search
Weather
California Privacy Notice

starkvilledailynews.com
304 E. Lampkin Street,
Starkville, MS 39759
Phone: 662-323-1642
Email: editor@starkvilledailynews.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Consent Preferences

Log In Using Your Account

MediWound Ltd. - Ordinary Shares (NQ:MDWD)

All News about MediWound Ltd. - Ordinary Shares

Sections

Services

Follow Us